Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
VAISHALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaishali Pharma Limited has submitted its financial results for the quarter and half-year ended September 30, 2025 to the stock exchange. This is a standard regulatory filing under listing obligations, confirming timely submission of Q2 FY26 results. The actual financial figures and detailed performance metrics were not disclosed in this notice and would be available in the accompanying results document. Investors will need to review the detailed results for revenue, profit, and other key indicators.
This is a routine compliance filing with no direct impact on share price. Investors should look at the actual results document for Vaishali Pharma's Q2 FY26 performance, including revenue growth, margins, and profitability, to assess the stock's outlook.